Veterinary medicines European public assessment report (EPAR): Tulaven, tulathromycin, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Tulaven, tulathromycin, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Tulaven, tulathromycin, Status: Authorised
EMA/PE/0000227301
Human medicines European public assessment report (EPAR): Menveo, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 15/03/2010, Date of refusal: 17/12/2009, Revision: 39, Status: Authorised
IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants
Veterinary medicines European public assessment report (EPAR): Rabigen SAG2, live vaccine against rabies, Status: Authorised
Human medicines European public assessment report (EPAR): Vaxelis, diphtheria, tetanus, pertussis (acellular, component), hepatitis B (rDNA), poliomyelitis (inactivated) and Haemophilus type b conjugate vaccine (adsorbed), Date of authorisation: 15/02/2016, Revision: 17, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Rhiniseng, inactivated vaccine to prevent progressive and non-progressive atrophic rhinitis in pigs, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Rexxolide, tulathromycin, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Respiporc FLUpan H1N1, porcine influenza vaccine (inactivated), Status: Authorised
EMEA-001556-PIP02-24